Concepts (240)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Venezuela | 8 | 2020 | 172 | 1.51 | Why? |
| Ataxia | 2 | 2020 | 133 | 1.44 | Why? |
| Colombia | 13 | 2021 | 1241 | 1.15 | Why? |
| Zika Virus Infection | 5 | 2018 | 1920 | 1.14 | Why? |
| Ageusia | 2 | 2020 | 918 | 0.95 | Why? |
| Indians, South American | 2 | 2021 | 126 | 0.84 | Why? |
| Helminthiasis | 1 | 2021 | 78 | 0.82 | Why? |
| Catholicism | 1 | 2020 | 64 | 0.80 | Why? |
| Ceremonial Behavior | 1 | 2020 | 63 | 0.78 | Why? |
| Alice in Wonderland Syndrome | 1 | 2018 | 2 | 0.78 | Why? |
| Parasitic Diseases | 1 | 2020 | 84 | 0.77 | Why? |
| Corynebacterium diphtheriae | 1 | 2018 | 19 | 0.75 | Why? |
| Kyasanur Forest Disease | 1 | 2017 | 9 | 0.72 | Why? |
| Transients and Migrants | 2 | 2021 | 1468 | 0.72 | Why? |
| Dengue | 2 | 2021 | 1565 | 0.70 | Why? |
| Alphavirus Infections | 1 | 2018 | 68 | 0.69 | Why? |
| Alphavirus | 1 | 2018 | 90 | 0.69 | Why? |
| Diphtheria | 1 | 2018 | 74 | 0.69 | Why? |
| Encephalomyelitis, Venezuelan Equine | 1 | 2017 | 16 | 0.69 | Why? |
| Ocular Motility Disorders | 1 | 2017 | 55 | 0.68 | Why? |
| Antiparasitic Agents | 1 | 2020 | 267 | 0.68 | Why? |
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2021 | 449 | 0.67 | Why? |
| Leishmaniasis, Cutaneous | 1 | 2017 | 48 | 0.67 | Why? |
| Antiprotozoal Agents | 1 | 2017 | 83 | 0.66 | Why? |
| Microcephaly | 1 | 2018 | 181 | 0.61 | Why? |
| Coinfection | 3 | 2021 | 6820 | 0.60 | Why? |
| Enterovirus Infections | 1 | 2020 | 404 | 0.59 | Why? |
| Picornaviridae Infections | 1 | 2020 | 544 | 0.57 | Why? |
| South America | 4 | 2021 | 565 | 0.56 | Why? |
| Dengue Virus | 1 | 2021 | 910 | 0.52 | Why? |
| Emigration and Immigration | 1 | 2019 | 501 | 0.51 | Why? |
| Olfaction Disorders | 2 | 2020 | 3704 | 0.46 | Why? |
| Seizures | 1 | 2020 | 1163 | 0.44 | Why? |
| Genome, Viral | 7 | 2021 | 13157 | 0.44 | Why? |
| Bibliometrics | 2 | 2020 | 731 | 0.42 | Why? |
| Ivermectin | 1 | 2020 | 973 | 0.42 | Why? |
| Infectious Disease Transmission, Vertical | 2 | 2018 | 5164 | 0.42 | Why? |
| Epidemics | 4 | 2020 | 6407 | 0.41 | Why? |
| Communicable Diseases, Emerging | 3 | 2020 | 2523 | 0.39 | Why? |
| Headache | 1 | 2020 | 2257 | 0.39 | Why? |
| Carcinoma, Squamous Cell | 1 | 2018 | 902 | 0.39 | Why? |
| Diagnostic Tests, Routine | 1 | 2021 | 2643 | 0.39 | Why? |
| Genetic Variation | 2 | 2021 | 3919 | 0.39 | Why? |
| Milk, Human | 1 | 2018 | 956 | 0.38 | Why? |
| Cytokines | 3 | 2021 | 15010 | 0.38 | Why? |
| Refugees | 1 | 2019 | 809 | 0.38 | Why? |
| Malaria | 1 | 2019 | 1097 | 0.38 | Why? |
| Chiroptera | 5 | 2021 | 3530 | 0.37 | Why? |
| Latin America | 3 | 2020 | 1721 | 0.36 | Why? |
| Influenza A virus | 1 | 2020 | 2234 | 0.36 | Why? |
| Phylogeny | 5 | 2021 | 13341 | 0.36 | Why? |
| Guillain-Barre Syndrome | 2 | 2020 | 1495 | 0.36 | Why? |
| Brain Diseases | 1 | 2020 | 1463 | 0.36 | Why? |
| Breast Feeding | 1 | 2018 | 1585 | 0.33 | Why? |
| Travel | 3 | 2020 | 7220 | 0.32 | Why? |
| Horses | 2 | 2018 | 474 | 0.30 | Why? |
| Influenza, Human | 2 | 2020 | 10779 | 0.30 | Why? |
| Skin Neoplasms | 1 | 2018 | 1679 | 0.28 | Why? |
| Saliva | 1 | 2021 | 4679 | 0.28 | Why? |
| Research | 1 | 2017 | 2115 | 0.27 | Why? |
| RNA, Viral | 7 | 2021 | 32276 | 0.26 | Why? |
| Disease Reservoirs | 3 | 2021 | 1672 | 0.25 | Why? |
| Humans | 57 | 2021 | 930598 | 0.25 | Why? |
| Drug Repositioning | 2 | 2020 | 5683 | 0.23 | Why? |
| SARS Virus | 3 | 2020 | 13021 | 0.23 | Why? |
| Fever | 2 | 2020 | 7795 | 0.23 | Why? |
| Zoonoses | 4 | 2020 | 3034 | 0.22 | Why? |
| Rainforest | 1 | 2020 | 37 | 0.22 | Why? |
| Zika Virus | 3 | 2018 | 1924 | 0.21 | Why? |
| Cholesteatoma, Middle Ear | 1 | 2020 | 32 | 0.21 | Why? |
| Ear, Middle | 1 | 2020 | 61 | 0.20 | Why? |
| Systemic Inflammatory Response Syndrome | 1 | 2020 | 6653 | 0.20 | Why? |
| Caribbean Region | 1 | 2021 | 349 | 0.20 | Why? |
| Geography, Medical | 2 | 2020 | 537 | 0.19 | Why? |
| Poultry | 1 | 2020 | 437 | 0.19 | Why? |
| Frontal Lobe | 1 | 2020 | 191 | 0.19 | Why? |
| Coronavirus Infections | 15 | 2020 | 253789 | 0.19 | Why? |
| Pneumonia, Viral | 14 | 2020 | 243684 | 0.18 | Why? |
| Osteoclasts | 1 | 2018 | 67 | 0.18 | Why? |
| Ecosystem | 2 | 2021 | 776 | 0.18 | Why? |
| Reverse Transcriptase Polymerase Chain Reaction | 5 | 2021 | 13720 | 0.18 | Why? |
| Hepatitis | 1 | 2020 | 160 | 0.18 | Why? |
| Plasmodium vivax | 1 | 2019 | 154 | 0.18 | Why? |
| Betacoronavirus | 13 | 2020 | 204454 | 0.17 | Why? |
| Th2 Cells | 1 | 2021 | 680 | 0.17 | Why? |
| Acyclovir | 1 | 2017 | 154 | 0.16 | Why? |
| Benchmarking | 1 | 2021 | 627 | 0.16 | Why? |
| Tick-Borne Diseases | 1 | 2017 | 68 | 0.16 | Why? |
| New York City | 5 | 2021 | 7432 | 0.16 | Why? |
| Enterovirus | 1 | 2020 | 402 | 0.16 | Why? |
| Animals | 11 | 2021 | 78931 | 0.16 | Why? |
| Giant Cells | 1 | 2018 | 334 | 0.15 | Why? |
| Hyponatremia | 1 | 2020 | 371 | 0.15 | Why? |
| DNA Mutational Analysis | 1 | 2018 | 581 | 0.15 | Why? |
| North America | 1 | 2020 | 1400 | 0.15 | Why? |
| Flavivirus | 1 | 2017 | 182 | 0.15 | Why? |
| Pandemics | 16 | 2021 | 389249 | 0.15 | Why? |
| Plasmodium falciparum | 1 | 2019 | 337 | 0.15 | Why? |
| Th1 Cells | 1 | 2021 | 1228 | 0.14 | Why? |
| Female | 21 | 2021 | 380317 | 0.14 | Why? |
| Rhinovirus | 1 | 2020 | 979 | 0.13 | Why? |
| Geography | 1 | 2020 | 1801 | 0.13 | Why? |
| Molecular Epidemiology | 1 | 2020 | 1638 | 0.13 | Why? |
| Neurons | 1 | 2020 | 864 | 0.13 | Why? |
| Coleoptera | 1 | 2013 | 13 | 0.13 | Why? |
| Fatal Outcome | 2 | 2020 | 3438 | 0.13 | Why? |
| Reagent Kits, Diagnostic | 2 | 2021 | 2149 | 0.13 | Why? |
| Polymorphism, Genetic | 1 | 2021 | 1074 | 0.13 | Why? |
| Orthomyxoviridae Infections | 1 | 2020 | 1001 | 0.13 | Why? |
| Nasopharynx | 3 | 2021 | 10224 | 0.12 | Why? |
| Limit of Detection | 1 | 2021 | 2698 | 0.12 | Why? |
| Viral Tropism | 1 | 2021 | 1329 | 0.12 | Why? |
| Lung | 5 | 2021 | 31049 | 0.12 | Why? |
| Public Health | 1 | 2018 | 16359 | 0.12 | Why? |
| Animals, Wild | 1 | 2020 | 1028 | 0.12 | Why? |
| Severe Acute Respiratory Syndrome | 3 | 2021 | 12361 | 0.12 | Why? |
| Publications | 1 | 2017 | 463 | 0.12 | Why? |
| Cell Differentiation | 1 | 2018 | 1338 | 0.12 | Why? |
| Blister | 1 | 2013 | 119 | 0.11 | Why? |
| Orthomyxoviridae | 1 | 2020 | 1168 | 0.11 | Why? |
| Camelus | 1 | 2020 | 1425 | 0.11 | Why? |
| Disease Outbreaks | 3 | 2020 | 27595 | 0.11 | Why? |
| Male | 17 | 2021 | 367725 | 0.11 | Why? |
| Pulmonary Embolism | 2 | 2021 | 4775 | 0.11 | Why? |
| Military Personnel | 1 | 2021 | 1097 | 0.11 | Why? |
| History, 21st Century | 1 | 2018 | 1849 | 0.11 | Why? |
| Epidemiological Monitoring | 2 | 2020 | 3493 | 0.10 | Why? |
| Dermatitis | 1 | 2013 | 188 | 0.10 | Why? |
| Multiple Organ Failure | 1 | 2020 | 1724 | 0.10 | Why? |
| Endothelial Cells | 1 | 2020 | 2048 | 0.10 | Why? |
| Autopsy | 4 | 2021 | 3495 | 0.09 | Why? |
| Acute Disease | 2 | 2020 | 6029 | 0.09 | Why? |
| Carrier State | 1 | 2020 | 2100 | 0.09 | Why? |
| Middle East Respiratory Syndrome Coronavirus | 2 | 2020 | 8843 | 0.09 | Why? |
| Viruses | 1 | 2021 | 2238 | 0.08 | Why? |
| Adult | 12 | 2021 | 244371 | 0.08 | Why? |
| Mothers | 1 | 2018 | 1624 | 0.08 | Why? |
| Polymorphism, Single Nucleotide | 1 | 2020 | 3607 | 0.08 | Why? |
| Infant | 3 | 2021 | 30274 | 0.08 | Why? |
| Child, Preschool | 3 | 2021 | 36283 | 0.08 | Why? |
| Child | 4 | 2021 | 70012 | 0.08 | Why? |
| Brain | 2 | 2021 | 5133 | 0.08 | Why? |
| Middle Aged | 13 | 2021 | 270681 | 0.08 | Why? |
| Liver | 1 | 2020 | 4007 | 0.08 | Why? |
| World Health Organization | 1 | 2019 | 4213 | 0.07 | Why? |
| Sensitivity and Specificity | 3 | 2021 | 22971 | 0.07 | Why? |
| Immunoglobulins, Intravenous | 1 | 2017 | 2705 | 0.07 | Why? |
| Adolescent | 4 | 2021 | 86841 | 0.07 | Why? |
| Aged, 80 and over | 6 | 2021 | 88759 | 0.07 | Why? |
| Chloroquine | 1 | 2020 | 3152 | 0.07 | Why? |
| Communicable Diseases | 1 | 2018 | 2148 | 0.06 | Why? |
| Specimen Handling | 1 | 2021 | 6190 | 0.06 | Why? |
| Europe | 1 | 2020 | 12702 | 0.06 | Why? |
| Diagnosis, Differential | 1 | 2017 | 7220 | 0.06 | Why? |
| Tertiary Care Centers | 1 | 2020 | 8248 | 0.06 | Why? |
| Young Adult | 5 | 2021 | 93724 | 0.06 | Why? |
| Viral Proteins | 1 | 2021 | 7370 | 0.06 | Why? |
| Aged | 8 | 2021 | 215776 | 0.06 | Why? |
| Virus Internalization | 1 | 2020 | 7921 | 0.06 | Why? |
| Biopsy | 2 | 2020 | 2811 | 0.06 | Why? |
| Population Surveillance | 1 | 2018 | 4967 | 0.05 | Why? |
| Viral Load | 1 | 2021 | 15850 | 0.05 | Why? |
| Time Factors | 2 | 2021 | 31397 | 0.05 | Why? |
| Mutation | 1 | 2020 | 12376 | 0.05 | Why? |
| Communicable Disease Control | 2 | 2020 | 29620 | 0.05 | Why? |
| Rodent Diseases | 1 | 2020 | 115 | 0.05 | Why? |
| Primate Diseases | 1 | 2020 | 110 | 0.05 | Why? |
| Gene-Environment Interaction | 1 | 2020 | 127 | 0.05 | Why? |
| Virus Replication | 1 | 2020 | 14331 | 0.05 | Why? |
| Myocardium | 2 | 2021 | 2323 | 0.05 | Why? |
| Confidence Intervals | 1 | 2021 | 744 | 0.05 | Why? |
| Real-Time Polymerase Chain Reaction | 1 | 2018 | 11367 | 0.05 | Why? |
| Blood Vessels | 1 | 2020 | 228 | 0.05 | Why? |
| Rodentia | 1 | 2020 | 235 | 0.05 | Why? |
| Animals, Domestic | 1 | 2020 | 272 | 0.04 | Why? |
| Microscopy, Electron, Transmission | 1 | 2020 | 605 | 0.04 | Why? |
| Inflammation | 1 | 2020 | 13255 | 0.04 | Why? |
| Mammals | 1 | 2020 | 315 | 0.04 | Why? |
| Primates | 1 | 2020 | 584 | 0.04 | Why? |
| Egypt | 1 | 2021 | 1211 | 0.04 | Why? |
| Spleen | 1 | 2021 | 877 | 0.04 | Why? |
| Plasmapheresis | 1 | 2020 | 437 | 0.04 | Why? |
| Kidney | 2 | 2021 | 3648 | 0.04 | Why? |
| Pulmonary Alveoli | 1 | 2021 | 867 | 0.04 | Why? |
| Infant, Newborn | 1 | 2017 | 23105 | 0.04 | Why? |
| Bias | 1 | 2021 | 1109 | 0.04 | Why? |
| Host Specificity | 1 | 2020 | 926 | 0.04 | Why? |
| Pregnancy | 1 | 2018 | 23879 | 0.04 | Why? |
| Spatial Analysis | 1 | 2021 | 878 | 0.04 | Why? |
| Central Nervous System | 1 | 2020 | 701 | 0.03 | Why? |
| Datasets as Topic | 1 | 2021 | 1404 | 0.03 | Why? |
| Lymph Nodes | 1 | 2020 | 1060 | 0.03 | Why? |
| Observational Studies as Topic | 1 | 2021 | 1887 | 0.03 | Why? |
| New York | 1 | 2021 | 2488 | 0.03 | Why? |
| Pulmonary Artery | 1 | 2020 | 803 | 0.03 | Why? |
| Enoxaparin | 1 | 2020 | 1064 | 0.03 | Why? |
| Clinical Laboratory Techniques | 1 | 2020 | 23402 | 0.03 | Why? |
| Vaccination | 1 | 2018 | 19050 | 0.03 | Why? |
| Health Knowledge, Attitudes, Practice | 1 | 2015 | 8811 | 0.03 | Why? |
| Severity of Illness Index | 1 | 2020 | 48226 | 0.03 | Why? |
| Hospitalization | 2 | 2020 | 54280 | 0.03 | Why? |
| Alveolar Epithelial Cells | 1 | 2020 | 1445 | 0.03 | Why? |
| Delivery of Health Care | 1 | 2018 | 15909 | 0.03 | Why? |
| Pregnancy Complications, Infectious | 1 | 2018 | 11559 | 0.03 | Why? |
| Disease Progression | 2 | 2020 | 13580 | 0.03 | Why? |
| Apoptosis | 1 | 2020 | 2335 | 0.03 | Why? |
| Inflammation Mediators | 1 | 2021 | 2654 | 0.02 | Why? |
| Residence Characteristics | 1 | 2020 | 1927 | 0.02 | Why? |
| Retrospective Studies | 1 | 2020 | 105322 | 0.02 | Why? |
| Antibodies, Viral | 2 | 2020 | 51949 | 0.02 | Why? |
| Prevalence | 2 | 2021 | 25773 | 0.02 | Why? |
| Antiviral Agents | 2 | 2020 | 41703 | 0.02 | Why? |
| Blood Coagulation | 1 | 2021 | 2768 | 0.02 | Why? |
| Antimalarials | 1 | 2020 | 2505 | 0.02 | Why? |
| Genomics | 1 | 2020 | 3118 | 0.02 | Why? |
| Thromboembolism | 1 | 2020 | 2101 | 0.02 | Why? |
| Cause of Death | 1 | 2021 | 4823 | 0.02 | Why? |
| Internationality | 1 | 2020 | 3297 | 0.02 | Why? |
| Cough | 1 | 2020 | 4891 | 0.02 | Why? |
| Serologic Tests | 1 | 2020 | 4359 | 0.02 | Why? |
| Databases, Factual | 1 | 2020 | 6248 | 0.02 | Why? |
| Health Personnel | 1 | 2015 | 29646 | 0.02 | Why? |
| Seroepidemiologic Studies | 1 | 2021 | 10017 | 0.02 | Why? |
| Liver Diseases | 1 | 2020 | 2698 | 0.02 | Why? |
| Molecular Diagnostic Techniques | 1 | 2021 | 4239 | 0.02 | Why? |
| Cities | 1 | 2015 | 4937 | 0.02 | Why? |
| Reproducibility of Results | 1 | 2020 | 11304 | 0.02 | Why? |
| Communication | 1 | 2021 | 5206 | 0.02 | Why? |
| Immunity, Innate | 1 | 2021 | 6570 | 0.02 | Why? |
| Cross-Sectional Studies | 2 | 2020 | 53120 | 0.02 | Why? |
| Case-Control Studies | 1 | 2021 | 17671 | 0.01 | Why? |
| Host-Pathogen Interactions | 1 | 2021 | 11041 | 0.01 | Why? |
| Anticoagulants | 1 | 2020 | 9563 | 0.01 | Why? |
| Students | 1 | 2015 | 5255 | 0.01 | Why? |
| Global Health | 1 | 2021 | 13911 | 0.01 | Why? |
| Comorbidity | 1 | 2021 | 34796 | 0.01 | Why? |
| Intensive Care Units | 1 | 2020 | 29594 | 0.01 | Why? |
| China | 1 | 2020 | 50654 | 0.01 | Why? |
| Coronavirus | 1 | 2020 | 18339 | 0.01 | Why? |
| Surveys and Questionnaires | 1 | 2015 | 43792 | 0.01 | Why? |
Paniz-Mondolfi's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(240)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(375)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_